Dorsey Wright & Associates Astrazeneca PLC Transaction History

Dorsey Wright & Associates

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	SELL	$69.91 - $75.81 $246,223 - $267,002	-3,522 Reduced 9.21%	34,728 $2.49 Million
Q1 2023 Apr 19, 2023	SELL	$63.15 - $71.6 $151,686 - $171,983	-2,402 Reduced 5.91%	38,250 $2.65 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $2.2 Million - $2.86 Million	40,652 New	40,652 $2.76 Million
Q1 2021 Apr 27, 2021	SELL	$47.16 - $54.44 $3.82 Million - $4.41 Million	-80,997 Closed	0 $0
Q4 2020 Jan 28, 2021	SELL	$48.52 - $58.02 $71,033 - $84,941	-1,464 Reduced 1.78%	80,997 $4.05 Million
Q3 2020 Oct 28, 2020	BUY	$53.07 - $61.1 $76,102 - $87,617	1,434 Added 1.77%	82,461 $4.52 Million
Q2 2020 Jul 23, 2020	SELL	$43.1 - $55.31 $283,080 - $363,276	-6,568 Reduced 7.5%	81,027 $4.31 Million
Q1 2020 Apr 20, 2020	SELL	$37.79 - $51.33 $376,426 - $511,298	-9,961 Reduced 10.21%	87,595 $3.91 Million
Q4 2019 Jan 31, 2020	SELL	$42.46 - $50.46 $169,585 - $201,537	-3,994 Reduced 3.93%	97,556 $4.86 Million
Q3 2019 Oct 31, 2019	SELL	$40.12 - $45.47 $50,751 - $57,519	-1,265 Reduced 1.23%	101,550 $4.53 Million
Q2 2019 Jul 02, 2019	SELL	$37.28 - $41.68 $241,760 - $270,294	-6,485 Reduced 5.93%	102,815 $4.24 Million
Q1 2019 Apr 04, 2019	BUY	$35.49 - $43.02 $32,757 - $39,707	923 Added 0.85%	109,300 $4.42 Million
Q4 2018 Jan 07, 2019	SELL	$36.86 - $41.49 $1.39 Million - $1.57 Million	-37,757 Reduced 25.84%	108,377 $4.12 Million
Q3 2018 Oct 12, 2018	BUY	$34.76 - $39.72 $5.08 Million - $5.8 Million	146,134 New	146,134 $5.78 Million

1,336

477M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $220B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.